| Role of CD11c+ T-bet+ B cells in human health and disease JL Karnell, V Kumar, J Wang, S Wang, E Voynova, R Ettinger Cellular immunology 321, 40-45, 2017 | 160 | 2017 |
| Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell–mediated autoimmunity ER Walsh, P Pisitkun, E Voynova, JA Deane, BL Scott, RR Caspi, ... Proceedings of the National Academy of Sciences 109 (40), 16276-16281, 2012 | 98 | 2012 |
| Innate pathways to B‐cell activation and tolerance SP Crampton, E Voynova, S Bolland Annals of the New York Academy of Sciences 1183 (1), 58-68, 2010 | 78 | 2010 |
| Immunization with a DNA chimeric molecule encoding a hemagglutinin peptide and a scFv CD21-specific antibody fragment induces long-lasting IgM and CTL responses to influenza virus N Ivanovska, A Tchorbanov, J Prechl, V Maximova, E Voynova, ... Vaccine 24 (11), 1830-1837, 2006 | 74 | 2006 |
| Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models SK Panda, V Facchinetti, E Voynova, S Hanabuchi, JL Karnell, RN Hanna, ... The Journal of clinical investigation 128 (5), 1873-1887, 2018 | 60 | 2018 |
| Exposure of IgG to an acidic environment results in molecular modifications and in enhanced protective activity in sepsis IK Djoumerska‐Alexieva, JD Dimitrov, EN Voynova, S Lacroix‐Desmazes, ... The FEBS Journal 277 (14), 3039-3050, 2010 | 56 | 2010 |
| Selective silencing of DNA‐specific B lymphocytes delays lupus activity in MRL/lpr mice AI Tchorbanov, EN Voynova, NM Mihaylova, TA Todorov, M Nikolova, ... European journal of immunology 37 (12), 3587-3596, 2007 | 36 | 2007 |
| An antibody-based construct carrying DNA-mimotope and targeting CR1 (CD35) selectively suppresses human autoreactive B-lymphocytes E Voynova, A Tchorbanov, J Prechl, M Nikolova, M Baleva, A Erdei, ... Immunology letters 116 (2), 168-173, 2008 | 35 | 2008 |
| IgM-enriched human intravenous immunoglobulin suppresses T lymphocyte functions in vitro and delays the activation of T lymphocytes in hu-SCID mice T Vassilev, N Mihaylova, E Voynova, M Nikolova, M Kazatchkine, S Kaveri Clinical & Experimental Immunology 145 (1), 108-115, 2006 | 34 | 2006 |
| Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus EN Voynova, J Skinner, S Bolland The Journal of Immunology 194 (4), 1503-1513, 2015 | 33 | 2015 |
| Correction of autophagy impairment inhibits pathology in the NOD. H-2h4 mouse model of primary Sjögren's syndrome E Voynova, F Lefebvre, A Qadri, S Muller Journal of Autoimmunity 108, 102418, 2020 | 27 | 2020 |
| Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes EN Voynova, AI Tchorbanov, TA Todorov, TL Vassilev Lupus 14 (7), 543-550, 2005 | 24 | 2005 |
| Intravenous immunoglobulin with enhanced polyspecificity improves survival in experimental sepsis and aseptic systemic inflammatory response syndromes I Djoumerska-Alexieva, L Roumenina, A Pashov, J Dimitrov, M Hadzhieva, ... Molecular Medicine 21, 1002-1010, 2015 | 23 | 2015 |
| Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their FcγIIb receptor N Mihaylova, E Voynova, A Tchorbanov, M Nikolova, A Michova, ... International immunology 20 (2), 165-175, 2008 | 22 | 2008 |
| Simultaneous engagement of FcγIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity N Mihaylova, E Voynova, A Tchorbanov, P Dolashka-Angelova, J Bayry, ... Molecular immunology 47 (1), 123-130, 2009 | 17 | 2009 |
| Requirement for CD40/CD40L interactions for development of autoimmunity differs depending on specific checkpoint and costimulatory pathways E Voynova, T Mahmoud, LT Woods, GA Weisman, R Ettinger, ... ImmunoHorizons 2 (1), 54-66, 2018 | 16 | 2018 |
| Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia D Kovalovsky, JH Yoon, MG Cyr, S Simon, E Voynova, C Rader, ... Leukemia 35 (9), 2581-2591, 2021 | 14 | 2021 |
| Cutting edge: induction of inflammatory disease by adoptive transfer of an atypical NK cell subset E Voynova, CF Qi, B Scott, S Bolland The Journal of Immunology 195 (3), 806-809, 2015 | 14 | 2015 |
| Increased activity of a NK-specific CAR-NK framework targeting CD3 and CD5 for T-cell leukemias E Voynova, N Hawk, FA Flomerfelt, WG Telford, RE Gress, JA Kanakry, ... Cancers 14 (3), 524, 2022 | 11 | 2022 |
| From hematopoietic stem cell transplantation to chimeric antigen receptor therapy: advances, limitations and future perspectives E Voynova, D Kovalovsky Cells 10 (11), 2845, 2021 | 8 | 2021 |
